Cargando…
Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis
BACKGROUND: Emerging studies reported that combination of fluorescence in situ hybridization (FISH) and nuclear matrix protein 22 (NMP22) could increase the sensitivity and specificity of bladder carcinoma (BC) management. Nevertheless, the reports remain inconsistent. This meta-analysis was underta...
Autores principales: | Liang, Qindong, Zhang, Guangjie, Li, Wuxian, Wang, Jing, Sheng, Shangchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317485/ https://www.ncbi.nlm.nih.gov/pubmed/30643432 http://dx.doi.org/10.2147/OTT.S186065 |
Ejemplares similares
-
Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?
por: Stefanopoulos, Anastasios, et al.
Publicado: (2014) -
Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer
por: Choi, Hwa Sub, et al.
Publicado: (2010) -
The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer
por: Huang, Changkun, et al.
Publicado: (2022) -
Diagnostic and prognostic role of BTA, NMP22, survivin and cytology in urothelial carcinoma
por: Gong, Yu-Wen, et al.
Publicado: (2021) -
Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
por: Wang, Zijie, et al.
Publicado: (2017)